Clinical Trials Directory

Trials / Conditions / Platinum-resistant Recurrent Ovarian Cancer

Platinum-resistant Recurrent Ovarian Cancer

8 registered clinical trials studyying Platinum-resistant Recurrent Ovarian Cancer — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingAPG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced S
NCT06687070
Ascentage Pharma Group Inc.Phase 1
RecruitingA Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
NCT06434610
Shanghai Jiaolian Drug Research and Development Co., LtdPhase 2
Not Yet RecruitingA Study of QL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizum
NCT06509971
West China Second University HospitalPhase 2
UnknownA Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Ca
NCT05325229
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 2
UnknownLetrozole Combined With Anlotinib Hydrochloride in the Treatment of Platinum-resistant Recurrent Ovarian Cance
NCT04720807
Xinhua Hospital, Shanghai Jiao Tong University School of MedicinePhase 2
TerminatedNR in Chemo-induced Peripheral Neuropathy
NCT03642990
Donna Hammond, PhDPhase 2
UnknownAn uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN C
NCT03699449
Yonsei UniversityPhase 2
UnknownApatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer
NCT04348032
Chinese Academy of Medical SciencesPhase 2